These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 15219115)
1. [Heart failure with or without myocardial infarct. Which patient profits from defibrillator?]. Einecke D MMW Fortschr Med; 2004 Mar; 146(13):6. PubMed ID: 15219115 [No Abstract] [Full Text] [Related]
2. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death. Das M Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214 [TBL] [Abstract][Full Text] [Related]
3. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials. Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408 [TBL] [Abstract][Full Text] [Related]
4. Risk stratification for sudden death in heart failure. Farwell D; Gollob MH Minerva Cardioangiol; 2007 Jun; 55(3):379-84. PubMed ID: 17534256 [TBL] [Abstract][Full Text] [Related]
5. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Zareba W; Piotrowicz K; McNitt S; Moss AJ; Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580 [TBL] [Abstract][Full Text] [Related]
6. Timing of implantation of cardioverter-defibrillator after acute myocardial infarction. Huikuri HV Europace; 2010 Aug; 12(8):1057-8. PubMed ID: 20501470 [No Abstract] [Full Text] [Related]
7. [Risk stratification and prevention of sudden death in patients with heart failure]. Villacastín J; Bover R; Castellano NP; Moreno J; Morales R; García-Espinosa A Rev Esp Cardiol; 2004 Aug; 57(8):768-82. PubMed ID: 15282066 [TBL] [Abstract][Full Text] [Related]
8. Improved survival associated with prophylactic implantable defibrillators in elderly patients with prior myocardial infarction and depressed ventricular function: a MADIT-II substudy. Huang DT; Sesselberg HW; McNitt S; Noyes K; Andrews ML; Hall WJ; Dick A; Daubert JP; Zareba W; Moss AJ; J Cardiovasc Electrophysiol; 2007 Aug; 18(8):833-8. PubMed ID: 17537209 [TBL] [Abstract][Full Text] [Related]
9. Primary prevention of sudden cardiac death: apart from the defibrillator, what is important in patients with myocardial infarction or heart failure? Kallergis EM; Vardas PE Hellenic J Cardiol; 2007; 48(2):89-93. PubMed ID: 17489346 [No Abstract] [Full Text] [Related]
10. Prognostic role of post-infarction C-reactive protein in patients undergoing implantation of cardioverter-defibrillators: design of the C-reactive protein Assessment after Myocardial Infarction to GUide Implantation of DEfibrillator (CAMI GUIDE) study. Bellocci F; Biasucci LM; Gensini GF; Padeletti L; Raviele A; Santini M; Giubilato G; Landolina M; Biondi-Zoccai G; Raciti G; Sassara M; Castro A; Kheir A; Crea F J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):293-9. PubMed ID: 17413310 [TBL] [Abstract][Full Text] [Related]
11. [Indication of implantable cardioverter defibrillator for heart failure]. Noda T; Kamakura S Nihon Rinsho; 2007 May; 65 Suppl 5():195-9. PubMed ID: 17571384 [No Abstract] [Full Text] [Related]
12. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591 [TBL] [Abstract][Full Text] [Related]
13. [Sudden cardiac death: who benefits from an implantable defibrillator?]. Sticherling C Praxis (Bern 1994); 2005 May; 94(21):869-73. PubMed ID: 15966486 [No Abstract] [Full Text] [Related]
14. Primary prevention with defibrillator therapy in women: results from the Sudden Cardiac Death in Heart Failure Trial. Russo AM; Poole JE; Mark DB; Anderson J; Hellkamp AS; Lee KL; Johnson GW; Domanski M; Bardy GH J Cardiovasc Electrophysiol; 2008 Jul; 19(7):720-4. PubMed ID: 18373605 [TBL] [Abstract][Full Text] [Related]
15. Biventricular pacing and defibrillator use in chronic heart failure. Cesario DA; Turner JW; Dec GW Cardiol Clin; 2007 Nov; 25(4):595-603; vii. PubMed ID: 18063163 [TBL] [Abstract][Full Text] [Related]
16. [Implantable cardioverter-defibrillators and mortality after myocardial infarct]. Bonhorst D Rev Port Cardiol; 1997 Apr; 16(4):355-7. PubMed ID: 9254125 [No Abstract] [Full Text] [Related]
17. Clinical trials update: sudden cardiac death prevention by implantable device therapy. Finch NJ; Leman RB Crit Care Nurs Clin North Am; 2005 Mar; 17(1):33-8, x. PubMed ID: 15749399 [TBL] [Abstract][Full Text] [Related]
18. Implantable cardioverter-defibrillator therapy after acute myocardial infarction: the results are not shocking. Goldberger JJ; Passman R J Am Coll Cardiol; 2009 Nov; 54(22):2001-5. PubMed ID: 19926004 [TBL] [Abstract][Full Text] [Related]
19. Reducing mortality with device therapy in heart failure patients without ventricular arrhythmias. Chapa DW; Lee HJ; Kao CW; Friedmann E; Thomas SA; Anderson J; Bardy GH Am J Crit Care; 2008 Sep; 17(5):443-52; quiz 453. PubMed ID: 18776000 [TBL] [Abstract][Full Text] [Related]
20. [Task Force on Sudden Cardiac Death, European Society of Cardiology. Summary of recommendations]. Priori SG; Aliot E; Blømstrom-Lundqvist C; Bossaert L; Breithardt G; Brugada P; Camm JA; Cappato R; Cobbe SM; Di Mario C; Maron BJ; McKenna WJ; Pedersen AK; Ravens U; Schwartz PJ; Trusz-Gluza M; Vardas P; Wellens HJ; Zipes DP; Ital Heart J Suppl; 2002 Oct; 3(10):1051-65. PubMed ID: 12478833 [No Abstract] [Full Text] [Related] [Next] [New Search]